ArticleBundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz2026
[Exposure inquiries related to preparations containing plant-based ingredients in Germany: analysis of inquiries (2013-2022) at the Joint Poison Information Center in Erfurt].
Article in Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPreparations containing plant-derived components, such as those found in herbal medicinal products, medical devices, dietary supplements, and cosmetics, are readily accessible and may lead to adverse effects or poisoning if used incorrectly. Poison information centers (PICs) respond to exposure-related inquiries. The aim of this study was to analyze exposure inquiries concerning preparations with plant-derived components at the Joint Poison Information Center in Erfurt (GGIZ) in order to identify preventive approaches.
methodsA statistical analysis of exposure inquiries received by the GGIZ from 2013 to 2022 was conducted. Data from nine federal states were included. Only inquiries related to single preparations that had been reported at least 10 times were considered. Symptom severity was assessed using the poisoning severity score (PSS), and poisoning risk was calculated using a modified Litovitz risk factor.
resultsA total of 36 preparations with 2512 exposures (mean 251.2/year; trend τ = 0.8667, p = 0.0007) were identified. Of those affected, 60.2% (1511) were toddlers. Most exposures (98.5%, 2474) occurred in the home environment. In 64.5% (1620) of cases, exposures were unintentional. Oral exposure accounted for 93.4% (2345) of cases. Of the exposures with known outcomes, 75.3% (1780/2365) remained asymptomatic, 23.5% (556/2365) resulted in minor/mild symptoms, 1% (24) in moderate symptoms, and 0.2% (5) in severe symptoms. Severe intoxications were associated with Colchysat® Bürger and Klosterfrau® Melissengeist concentrate. DISCUSSION: Toddlers represent a relevant risk group in the use of preparations containing plant-derived components. Preparations containing colchicine or ethanol may lead to fatal intoxications, particularly in cases of intentional exposure. It is recommended to store oral and topical preparations separately and out of reach of unauthorized persons, and to provide comprehensive education.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.